1. Home
  2. APPS vs CRVS Comparison

APPS vs CRVS Comparison

Compare APPS & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digital Turbine Inc.

APPS

Digital Turbine Inc.

HOLD

Current Price

$8.09

Market Cap

974.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$13.24

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APPS
CRVS
Founded
N/A
2014
Country
United States
United States
Employees
620
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
974.7M
1.1B
IPO Year
2012
2016

Fundamental Metrics

Financial Performance
Metric
APPS
CRVS
Price
$8.09
$13.24
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$6.25
$30.17
AVG Volume (30 Days)
2.9M
1.0M
Earning Date
06-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
62.92
48.04
EPS
N/A
N/A
Revenue
$103,569,000.00
N/A
Revenue This Year
$15.60
N/A
Revenue Next Year
$11.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
38.55
N/A
52 Week Low
$2.74
$4.05
52 Week High
$13.60
$26.95

Technical Indicators

Market Signals
Indicator
APPS
CRVS
Relative Strength Index (RSI) 40.88 42.99
Support Level $3.85 $12.95
Resistance Level $8.28 $14.00
Average True Range (ATR) 0.67 0.71
MACD -0.20 -0.23
Stochastic Oscillator 5.94 22.47

Price Performance

Historical Comparison
APPS
CRVS

About APPS Digital Turbine Inc.

Digital Turbine Inc is an independent mobile growth platform that levels up the landscape for advertisers, publishers, carriers, and device original equipment manufacturers. The Company offers end-to-end products and solutions leveraging proprietary technology to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. In addition, its products and solutions provide monetization opportunities for OEMs, carriers, and application (app or apps) publishers and developers.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: